Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy (dataset)

Isobella Honeyborne (Creator)
Timothy D. McHugh (Creator)
Iitu Kuittinen (Creator)
Anna Cichonska (Creator)
Dimitrios Evangelopoulos (Creator)
Katharina Ronacher (Creator)
Paul D. van Helden (Creator)
Stephen Henry Gillespie (Creator)
Delmiro Fernandez-Reyes (Creator)
Gerhard Walzl (Creator)
Juho Rousu (Creator)
Philip D. Butcher (Creator)
Simon J. Waddell (Creator)

Dataset

Description

Study number: E-MTAB-3872

Date made available	12 Apr 2016
Publisher	EMBL-EBI

Contact

[email protected]

Access Dataset

E-MTAB-3872

2 Finished

IMI PREDICT TB: EU Innovative Medicines Initiative (IMI) 75% account
Gillespie, S. H. (PI)
European Commission
1/05/12 → 31/10/17
Project: Standard
Rapid Evolution of Biomarkers: Rapid Evaluation of Biomarkers in Tuberculosis
Gillespie, S. H. (PI)
Medical Research Council
1/07/11 → 31/10/11
Project: Standard

1 Article

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
Honeyborne, I., McHugh, T. D., Kuittinen, I., Cichonska, A., Evangelopoulos, D., Ronacher, K., van Helden, P. D., Gillespie, S. H., Fernandez-Reyes, D., Walzl, G., Rousu, J., Butcher, P. D. & Waddell, S. J., 7 Apr 2016, In: BMC Medicine. 14, 1, p. 1-13 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
36 Citations (Scopus)

5 Downloads (Pure)

Cite this